A. Johnson

发表

Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.

P. Timmermans, W. Price, J. Duncia, 1990, The Journal of pharmacology and experimental therapeutics.

Nonpeptide angiotensin II receptor antagonists.

P. Timmermans, W. Price, J. Duncia, 1990, American journal of hypertension.

The discovery of a new class of highly specific nonpeptide angiotensin II receptor antagonists.

P. Timmermans, W. Price, J. Duncia, 1991, American journal of hypertension.

Identification of angiotensin II receptor subtypes.

P. Timmermans, L. Pease, J. Duncia, 1989, Biochemical and biophysical research communications.

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

P. Timmermans, W. Price, J. Duncia, 1990, The Journal of pharmacology and experimental therapeutics.

Discrimination of angiotensin II receptor subtypes by dithiothreitol.

J. Duncia, R. Wexler, T. Nguyen, 1989, European journal of pharmacology.

Nonpeptide Angiotensin II Receptor Antagonists: Studies With EXP9270 and DuP 753

P. Timmermans, W. Price, J. Duncia, 1990, Hypertension.

Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.

T. Maduskuie, J. Billheimer, E. Shimshick, 1995, Journal of medicinal chemistry.

Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.

P. Timmermans, W. Price, J. Duncia, 1990, Hypertension.

Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8308.

P. Timmermans, W. Price, D. Carini, 1988, European journal of pharmacology.

Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307).

P. Timmermans, W. Price, D. Carini, 1988, The Journal of pharmacology and experimental therapeutics.

In vitro pharmacology of DuP 753.

P. Timmermans, W. Price, J. Duncia, 1991, American journal of hypertension.

Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.

P. Timmermans, W. Price, J. Duncia, 1990, The Journal of pharmacology and experimental therapeutics.

The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist

P. Timmermans, W. Price, J. Duncia, 1992, Medicinal research reviews.

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.

W. Price, J. Duncia, J. Santella, 1991, Journal of medicinal chemistry.

Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.

W. Price, P. Wong, J. Stump, 1985, Journal of medicinal chemistry.

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

P. Timmermans, W. Price, J. Duncia, 1990, The Journal of pharmacology and experimental therapeutics.

Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.

P. Timmermans, W. Price, J. Duncia, 1989, The Journal of pharmacology and experimental therapeutics.

Novel piperidine sigma receptor ligands as potential antipsychotic drugs.

J F McElroy, K. Rohrbach, A L Johnson, 1992, Journal of medicinal chemistry.

Affinity chromatography of the anterior pituitary D2-dopamine receptor.

M. Caron, S. Senogles, N. Amlaiky, 1986, Biochemistry.

Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.

P. Timmermans, W. Price, J. Duncia, 1990, Journal of medicinal chemistry.

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.

P. Timmermans, W. Price, J. Duncia, 1990, Journal of medicinal chemistry.

Angiotensin II Receptor Antagonists From Discovery to Antihypertensive Drugs

P. Timmermans, W. Price, J. Duncia, 1991, Hypertension.

In vivo pharmacology of DuP 753.

P. Timmermans, W. Price, J. Duncia, 1991, American journal of hypertension.

Chicken sterol carrier protein 2/sterol carrier protein x: cDNA cloning reveals evolutionary conservation of structure and regulated expression.

J. Strauss, A. Ryan, R. Deeley, 1993, Archives of biochemistry and biophysics.

Rationale for the chemical development of angiotensin II receptor antagonists.

P. Timmermans, J. Duncia, R. Wexler, 1992, American journal of hypertension.

Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.

T. Maduskuie, J. Billheimer, C. Higley, 1994, Journal of medicinal chemistry.

Angiotensin II receptor heterogeneity.

L. Pease, J. Duncia, R. Wexler, 1991, American journal of hypertension.

Nonpeptide angiotensin II receptor antagonists: a novel class of antihypertensive agents.

P. Timmermans, W. Price, J. Duncia, 1990, Blood vessels.

Nonpeptide angiotensin II receptor antagonists.

P. Timmermans, W. Price, J. Duncia, 1990, Trends in pharmacological sciences.

EXP 6803, A Nonpeptide Angiotensin II Receptor Antagonist

P. Timmermans, W. Price, J. Duncia, 1989 .